Aug 18: Resolve360 is a physical medicine and rehabilitation company that provides evidence-based, personalized rehabilitation programs for individuals suffering from neuromuscular and musculoskeletal disorders. Resolve360 has been granted an Indian patent for its proprietary rehabilitation methodology, marking a significant milestone in the evolution of physical medicine and rehabilitation. The patented methodology introduces a structured, evidence-based framework for treating neuromuscular and musculoskeletal (NMSK) disorders, covering the entire patient journey from prognosis and personalized protocol creation to treatment delivery, monitoring, and long-term recovery. The patent, titled “System and Method for Prognosis, Protocol Creation, Delivery & Execution for Neuromuscular and Musculoskeletal Disorders,” was granted by the Patent Office, Government of India in July 2026.
The methodology is the outcome of nearly a decade of clinical learning. The concept was first envisioned in 2016, with Resolve360 being founded in 2019 to develop and refine the approach through continuous clinical practice. After years of research, patient feedback, and protocol optimization, the company filed its patent application in 2024, receiving the grant in 2026. During this journey, Resolve360 has treated over thousands of patients and delivered 20+ lakh rehabilitation sessions, helping validate and strengthen the effectiveness of the methodology across a wide range of neuromuscular and musculoskeletal conditions.
Unlike conventional rehabilitation approaches that often focus on temporary pain relief, Resolve360’s methodology is designed to identify not only the primary root cause of a patient’s condition but also the interconnected underlying factors contributing to it. The methodology develops a comprehensive prognosis that addresses both the affected area and related musculoskeletal and neuromuscular regions, enabling a customized treatment pathway tailored to the patient’s overall clinical needs.
Dr. Apoorva Shrivastava, CEO and Founder Resolve360 and Shivam Gupta, Co-Founder, Resolve360
The innovation comes at a time when neuromuscular and musculoskeletal disorders are emerging as one of the fastest-growing health challenges globally. Sedentary lifestyles, prolonged screen time, and technology-driven routines have led to a sharp rise in chronic pain, muscle dysfunction, spinal disorders, ligament injuries, and mobility issues even among younger populations. As these conditions continue to increase, the need for scientifically designed, personalized rehabilitation has never been greater.
While physiotherapy became significantly more accessible through online consultations following the pandemic, rehabilitation practices remain largely fragmented. Many existing approaches continue to rely on generalized exercise plans or symptom-based pain management, often without standardized protocols for diagnosis, treatment execution, adherence, or long-term monitoring. More importantly, rehabilitation is often approached as an afterthought in the continuum of care rather than as a proven, structured treatment methodology in itself. Resolve360’s patented methodology seeks to address this gap by bringing structure, consistency, and clinical rigor to rehabilitation, transforming it from a reactive service into a comprehensive, protocol-driven treatment methodology.
Through its proprietary core clinical process flow and Seamless App, Resolve360 also delivers rehabilitation sessions to patients across geographies, enabling members of the Indian diaspora to access expert-led care remotely. The platform currently serves patients in the United States, the United Kingdom, Australia, the UAE, and other Gulf countries, extending evidence-based rehabilitation to individuals seeking personalized and continuous care regardless of location.
Commenting on the achievement, Dr. Apoorva Shrivastava, CEO Resolve360 and Inventor of the patented methodology, said:
“Every era faces its own health epidemic, and today’s epidemic is neuromuscular and musculoskeletal disorders driven by sedentary lifestyles and technology-centric living. Despite advances in healthcare, rehabilitation continues to lack standardized treatment methodologies that ensure consistent outcomes. This patent represents years of clinical learning brought together into a structured rehabilitation framework that focuses on identifying the root cause, delivering customized physical medicine in the right dosage, and guiding patients through complete recovery rather than temporary pain relief. Our vision is to establish physical medicine as a science-led discipline capable of delivering measurable, long-term outcomes.”
Looking ahead, Resolve360 is also building AI capabilities to support the future of rehabilitation. As the burden of musculoskeletal disorders continues to grow, the company believes that delivering personalized rehabilitation entirely through manual processes will become increasingly challenging. Its AI initiatives are therefore being developed to complement the patented methodology, helping clinicians enhance treatment personalization, monitoring, and clinical decision-making while preserving expert-led patient care.
The company’s growth has also been strengthened through seed funding from Kalaari Capital (investment amount undisclosed), which will support Resolve360’s expansion and its continued investment in research, technology, and innovation to make evidence-based rehabilitation more accessible and scalable.